FDA approves Valeant's drug to treat plaque psoriasis
February 15, 2017 at 18:34 PM EST
Feb 15 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Valeant Pharmaceuticals International Inc's Siliq to treat adults with moderate-to-severe plaque psoriasis.
